Clinical Pharmacology of New Histamine H1 Receptor Antagonists

被引：0
|
作者：
F. Estelle R. Simons
Keith J. Simons
机构：
[1] The University of Manitoba,Faculty of Medicine
[2] and the Children’s Hospital of Winnipeg,Faculties of Pharmacy and Medicine
[3] The University of Manitoba,undefined
来源：
Clinical Pharmacokinetics | 1999年 / 36卷
关键词：
Adis International Limited; Allergy Clin Immunol; Terfenadine; Cetirizine; Loratadine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The recently introduced H1 receptor antagonists ebastine, fexofenadine and mizolastine, and the relatively new H1 antagonists acrivastine, astemizole, azelastine, cetirizine, levocabastine and loratadine, are diverse in terms of chemical structure and clinical pharmacology, although they have similar efficacy in the treatment of patients with allergic disorders.
引用
收藏
页码：329 / 352
页数：23
相关论文
共 50 条
  • [41] Histamine H1 receptor antagonists enhance the efficacy of antibacterials against Escherichia coli
    Bruer, G. G.
    Hagedorn, P.
    Kietzmann, M.
    Tohamy, A. F.
    Filor, V.
    Schultz, E.
    Mielke-Kuschow, S.
    Meissner, J.
    BMC VETERINARY RESEARCH, 2019, 15 (1)
  • [42] Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases
    Chu, Zhaoxing
    Cen, ab Lifang
    Xu, Qinlong
    Lin, Gaofeng
    Mo, Jiajia
    Shao, Li
    Zhao, Yan
    Li, Jiaming
    Ye, Wenfeng
    Fang, Tao
    Ren, Weijie
    Zhu, Qihua
    He, Guangwei
    Xu, Yungen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268
  • [43] Histamine H1 receptor antagonists enhance the efficacy of antibacterials against Escherichia coli
    G. G. Bruer
    P. Hagedorn
    M. Kietzmann
    A. F. Tohamy
    V. Filor
    E. Schultz
    S. Mielke-Kuschow
    J. Meissner
    BMC Veterinary Research, 15
  • [44] Inhibitory action of histamine H1 receptor antagonists on eosinophil functions in vitro and in vivo
    Furuta, A.
    Kanai, K.
    Asano, K.
    Suzaki, H.
    Suzuki, M.
    ALLERGY, 2010, 65 : 519 - 519
  • [45] Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
    Qu, Changbo
    Fuhler, Gwenny M.
    Pan, Yihang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [46] Changes in pH differently affect the binding properties of histamine H1 receptor antagonists
    Gillard, M
    Chatelain, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 530 (03) : 205 - 214
  • [47] The different effects of histamine H1 receptor antagonists on histamine-induced vasodilation in rat mesenteric arteries
    Narahara, Yukimi
    Hatutori, Sayo
    Koyama, Toshihiro
    Sun, Pengyuan
    Kitamura, Yoshihisa
    Takatori, Shingo
    Kawasaki, Hiromu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 210P - 210P
  • [48] EFFECTS OF HISTAMINE H1 AND H2 RECEPTOR ANTAGONISTS ON NEUROGENIC AND HUMORAL VASODILATOR RESPONSES
    POWELL, JR
    BRODY, MJ
    PHARMACOLOGIST, 1974, 16 (02): : 243 - 243
  • [49] HISTAMINE H1 RECEPTOR IS REQUIRED FOR ATHEROGENESIS
    Rozenberg, I.
    Akhmedov, A.
    Kouroedov, A.
    Mocharla, P.
    Watanabe, T.
    Boren, J.
    Odermatt, B.
    Luescher, T. F.
    Tanner, F. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 1 - 2
  • [50] Histamine H1 Receptor is Required for Atherogenesis
    Rozenberg, Izabela
    Mocharla, Pavani
    Becher, Burkhard
    Hofmann, Janin
    Akhmedov, Alexander
    Boren, Jan
    Luescher, Thomas F.
    Tanner, Felix C.
    CIRCULATION, 2008, 118 (18) : S410 - S411
12345